Upcoming Events

Click here to register.

Contact us at hrb-tmrn@universityofgalway.ie for more information

Interactive One-Day Workshop

Click here to Register

Participants can anticipate an informative and practical event that will equipping them with the tools to calculate sample size and assess study power, and an understanding that will help them navigate the intricacies of clinical trial planning and analysis.

A comprehensive overview of key steps in the process will be discussed, rationale explained, and several worked examples provided. Attendees will gain insights into techniques for obtaining or estimating effect size, a primary determinant of a required sample size. PI experience, common pitfalls and challenges will be discussed in a panel discussion.

Study day will end with a Statistics Clinic – you can bring your own problem to be discussed with a statistician (please email brief description in advance).

This Study Day is tailored for clinicians, students, researchers, and professionals involved in clinical trial design, conduct and analysis, with no or intermediate level of experience with statistical planning.

Contact us at hrb-tmrn@universityofgalway.ie for more information

Click here to register – Free event

Contact us at hrb-tmrn@universityofgalway.ie for more information

Venue: MRA201 The Ryan Institute Lecture Theatre, The Ryan Institute, University of Galway

WHO Chief Scientist to hold information session on the new WHO clinical trial guidance; Register Here for this important event on 13^th Dec 1300 GMT.

The publication of the “WHO guidance for best practices for clinical trials” in September 2024 was a major milestone. For the first time there is now global guidance applicable to design and conduct of all clinical trials (whether or not they include investigational products), also with relevance to observational studies.

Click HERE to register.

Key areas of focus include embedding research into health systems, developing sustained networks of continuously active clinical researchers, greater inclusivity of diverse population groups, the centrality of the need for interaction between patient/community groups and researchers in the trial life cycle, simplifying what can be excessively complex and uncoordinated clinical trial approval processes involving many bodies, and ensuring a risk-based, proportionate approach to design, data collection, oversight and inspection.

WHO and The Global Health Network are convening a global event to present the key aspects of this new guidance.

This will be an informative opportunity to hear directly from WHO and learn how this guidance can help support and strengthen your research. Live translation will be available.

Agenda

• Opening remarks, Dr Jeremy Farrar, WHO Chief Scientist
• Presentation, Dr Vasee Moorthy, WHO Senior Advisor, Research for Health
• Q&A Session

Objectives

• How can WHO enable your work in clinical research?
• Outline how stakeholders can use the guidance to advance patient-centered clinical research
• Discuss how implementation could lead to more enabling, more efficient clinical research ecosystems
• Raise awareness of a forthcoming Global Action Plan on Clinical Trial Ecosystem Strengthening
• Catalyse discussions on what stakeholder groups can do to take forward actions aligned with their strategies.

Registration is now open – Click here. 

This event will require a fully refundable registration deposit of €20. This is so we can reduce waste and cover unnecessary costs. Attendees will be refunded on arrival through Eventbrite. Please note: Refunds on Eventbrite typically take 5 to 7 business days to process.